Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development
Garcia C, Venkat A, McQuaid D, Agabiti S, Tong A, Mathew B, Cardone R, Starble R, Ruiz C, Zheng C, Sogunro A, Jacox J, Loh K, Kibbey R, Krishnaswamy S, Muzumdar M. Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. Nature Communications 2026 PMID: 41760660, DOI: 10.1038/s41467-026-69821-2.Peer-Reviewed Original Research
Pancreatic adenocarcinomaImmature B cellsCell-derived tumorsCell secretionCell transcriptional statesSingle-cell RNA sequencingHost metabolic statePancreatic adenocarcinoma developmentBona fide driversExperimental lineagesPeptide hormone cholecystokininTranscriptional statesB cellsCholecystokinin expressionAdenocarcinoma developmentCCK signalingSecretion of insulinHormone cholecystokininCell expressionRNA sequencingTumor formationCholecystokininPDAC developmentPDAC progressionIslet beta